Education
About Us
Working with TipRanks
Follow Us
Moolec Science (MLEC)
NASDAQ:MLEC
MLEC Stock Chart & Stats
$4.11
-$0.04(-4.25%)
At close: 4:00 PM EST
$4.11
-$0.04(-4.25%)
Day’s Range― - ―
52-Week Range$3.08 - $157.06
Previous CloseN/A
Volume11.69K
Average Volume (3M)209.37K
Market Cap
$6.72M
Enterprise Value$27.30M
Total Cash (Recent Filing)$1.93M
Total Debt (Recent Filing)$22.09M
Price to Earnings (P/E)―
Beta-0.72
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding726,118
10 Day Avg. Volume506,476
30 Day Avg. Volume209,369
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.12
P/FCF Ratio-1.35
Enterprise Value/Market Cap4.06
Enterprise Value/Revenue3.49
Enterprise Value/Gross Profit-42.69
Enterprise Value/Ebitda-5.24
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ImprovementA very large FY2025 revenue ramp alongside a jump in gross margin to ~34% indicates tangible commercialization traction for Moolec’s plant-produced ingredients. Sustained revenue growth with improving unit economics supports future operating leverage as fixed costs are absorbed over the next several quarters.
Distinct Molecular Farming NicheMoolec’s focus on molecular farming and seed-to-ingredient production targets a structurally growing market for alternative proteins and bioactive ingredients. This specialized platform can create durable competitive advantages via proprietary crops, scalable agriculture-based production, and differentiated go-to-market channels across regions.
Stronger Governance & Ops OversightBringing a quality and operations veteran onto the board and key committees strengthens oversight of manufacturing scale-up, compliance and internal controls. Improved governance reduces execution and regulatory risk during commercialization and supports credible operational discipline over the medium term.
Bears Say
Large Net Losses And Cash BurnSignificant accounting losses and persistent negative free cash flow imply ongoing reliance on external financing to fund operations. Continued cash burn constrains the company’s ability to invest organically, increases dilution risk, and raises the probability of funding shortfalls if operating improvements slow or capital markets tighten.
Weakened Balance Sheet & High LeverageNegative equity and elevated debt materially reduce financial flexibility and heighten refinancing and solvency risk. With leverage effectively high, the company faces constrained access to attractive capital, potential covenant pressures, and increased likelihood of dilution or distressed transactions if cash generation does not improve.
Listing Compliance Reliant On One-Time Accounting GainsRestoring Nasdaq compliance through derecognition gains tied to subsidiary bankruptcies is a non-recurring fix. Reliance on accounting events rather than operational improvement signals fragile core equity strength and creates persistent risk to U.S. listing status and investor confidence if those gains do not translate into sustainable financial health.
Moolec Science News
MLEC FAQ
What was Moolec Science’s price range in the past 12 months?
Moolec Science lowest stock price was $3.08 and its highest was $157.06 in the past 12 months.
What is Moolec Science’s market cap?
Moolec Science’s market cap is $6.72M.
When is Moolec Science’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Moolec Science’s earnings last quarter?
Currently, no data Available
Is Moolec Science overvalued?
According to Wall Street analysts Moolec Science’s price is currently Overvalued.
Does Moolec Science pay dividends?
Moolec Science does not currently pay dividends.
What is Moolec Science’s EPS estimate?
Moolec Science’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Moolec Science have?
Moolec Science has 726,118 shares outstanding.
What happened to Moolec Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Moolec Science?
Currently, no hedge funds are holding shares in MLEC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Moolec Science
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Technical Analysis
AIM ImmunoTech
―
Ensysce Biosciences
―
Cyclerion Therapeutics
―
―
Calidi Biotherapeutics
―